Better Dividend Stock: AbbVie or Johnson & Johnson?
The pharmaceutical industry is chock-full of companies that offer attractive dividends. AbbVie (NYSE: ABBV) and Johnson & Johnson (NYSE: JNJ) especially stand out. They're two of the largest drugmakers in the world with a long lineup of successful products.
But which is the better dividend stock? Here's how AbbVie and Johnson & Johnson stack up against each other.
Probably the first thing most investors look at with a dividend stock is the yield. You'll like what you see with AbbVie on this front. Its dividend yield currently stands at nearly 3.7%.
Source Fool.com
